Physician profile
Julia A Fowler
NPI 1023104320
$271.42
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $56.97 · 2021: $13.86.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $100.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $33.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.70 | 2019-2020 | |
| Amarin Pharma, INC. | $29.45 | 2020 | |
| Daiichi Sankyo INC. | $15.37 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.86 | 2021 | |
| Currax Pharmaceuticals LLC | $13.07 | 2019 | |
| Amgen INC. | $12.86 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $12.84 | 2019 | |
| Pfizer INC. | $11.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.